This study is not accepting new patients

Master Rollover Protocol for Continued Safety Assessment of Study Drug

a study on Cancer, General

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCLA
Dates
study started
Principal Investigator
by Dr. Parvin Fatheddin Peddi (ucla)

Description

Summary

This study is for patients who have participated in a previous study and who continue to receive benefit to have continued access to study drug and/or treatment.

Keywords

Cancer

Eligibility

You can join if…

Open to people ages 18 years and up

- To be eligible patients must be currently receiving benefit in a concluded Lilly study for a compound that has opened an addendum in the continued access protocol.

You CAN'T join if...

- Patients must not be concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.

Locations

  • UCLA Medical Center not accepting new patients
    Torrance California 90505 United States
  • Sarah Cannon Cancer Center not accepting new patients
    Nashville Tennessee 37203 United States
  • Fort Wayne Oncology & Hematology not accepting new patients
    Fort Wayne Indiana 46804 United States

Lead Scientist at University of California Health

Details

Status
not accepting new patients
Start Date
Sponsor
Eli Lilly and Company
ID
NCT02632994
Study Type
Expanded Access
Last Updated